BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
-14.73%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$5.16B
AUM Growth
+$5.16B
(-18%)
Cap. Flow
-$29M
Cap. Flow
% of AUM
-0.56%
Top 10 Holdings %
Top 10 Hldgs %
40.75%
Holding
231
New
16
Increased
80
Reduced
52
Closed
17
Top Buys
| 1 |
Black Diamond Therapeutics
BDTX
|
$33.2M |
| 2 |
Fate Therapeutics
FATE
|
$32.9M |
| 3 |
Intuitive Surgical
ISRG
|
$21.8M |
| 4 |
MTEM
Molecular Templates, Inc.
MTEM
|
$21.5M |
| 5 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$21M |
Top Sells
| 1 |
Teladoc Health
TDOC
|
$85.1M |
| 2 |
Bristol-Myers Squibb
BMY
|
$49.3M |
| 3 |
Moderna
MRNA
|
$29.5M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
$27.6M |
| 5 |
QuidelOrtho
QDEL
|
$21.9M |
Sector Composition
| 1 | Healthcare | 95.76% |
| 2 | Technology | 0.56% |
| 3 | Industrials | 0.54% |
| 4 | Communication Services | 0.17% |
| 5 | Financials | 0.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Illumina
ILMN
$15.8B
| $54.3M | 1.05% |
198,988
-22,679
| -10% | -$6.19M |
|
27
Arvinas
ARVN
$568M
| $51.2M | 0.99% |
1,269,303
+27,400
| +2% | +$1.1M |
|
28
Boston Scientific
BSX
$156B
| $50.3M | 0.98% |
1,541,225
-37,396
| -2% | -$1.22M |
|
29
Centene
CNC
$14.3B
| $48.1M | 0.93% |
810,270
+69,659
| +9% | +$4.14M |
|
30
Baxter International
BAX
$12.7B
| $48.1M | 0.93% |
591,921
+52,246
| +10% | +$4.24M |
|
31
Danaher
DHR
$147B
| $47.8M | 0.93% |
345,481
-21,112
| -6% | -$2.92M |
|
|
AKCA
32
DELISTED
Akcea Therapeutics, Inc. Common Stock
AKCA
| $45.8M | 0.89% |
3,204,244
+41,601
| +1% | +$595K |
|
|
ICPT
33
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $44.6M | 0.87% |
708,976
-6,200
| -0.9% | -$390K |
|
34
Edwards Lifesciences
EW
$47.8B
| $44.1M | 0.86% |
233,965
+31,222
| +15% | +$5.89M |
|
35
Charles River Laboratories
CRL
$8.04B
| $41.9M | 0.81% |
331,623
+48,525
| +17% | +$6.12M |
|
|
SAGE
36
DELISTED
Sage Therapeutics
SAGE
| $40.7M | 0.79% |
1,418,104
+109,250
| +8% | +$3.14M |
|
|
MTEM
37
DELISTED
Molecular Templates, Inc.
MTEM
| $38.7M | 0.75% |
2,910,640
+1,614,953
| +125% | +$21.5M |
|
38
Jazz Pharmaceuticals
JAZZ
$7.75B
| $37M | 0.72% |
371,337
-9,966
| -3% | -$994K |
|
|
MYOV
39
DELISTED
Myovant Sciences Ltd.
MYOV
| $36.4M | 0.71% |
4,815,109
| – | – |
|
40
MacroGenics
MGNX
$112M
| $35.6M | 0.69% |
6,119,150
+245,794
| +4% | +$1.43M |
|
41
Align Technology
ALGN
$10.3B
| $35.3M | 0.69% |
203,076
-75,627
| -27% | -$13.2M |
|
|
42
Fate Therapeutics
FATE
$120M
| $34.7M | 0.67% |
1,563,200
+1,480,400
| +1,788% | +$32.9M |
|
43
CRISPR Therapeutics
CRSP
$4.71B
| $33.9M | 0.66% |
800,462
+70,000
| +10% | +$2.97M |
|
|
44
Black Diamond Therapeutics
BDTX
$157M
| $33.2M | 0.64% |
+1,330,000
| New | +$33.2M |
|
45
Scholar Rock
SRRK
$3.14B
| $32.9M | 0.64% |
2,715,106
+80,640
| +3% | +$977K |
|
|
46
Teladoc Health
TDOC
$1.37B
| $31.2M | 0.6% |
201,235
-548,810
| -73% | -$85.1M |
|
|
HRC
47
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $29.7M | 0.58% |
295,479
+58,193
| +25% | +$5.85M |
|
48
Stryker
SYK
$150B
| $28.8M | 0.56% |
172,713
+11,458
| +7% | +$1.91M |
|
49
CareDx
CDNA
$727M
| $27.9M | 0.54% |
1,277,051
+100,321
| +9% | +$2.19M |
|
50
DexCom
DXCM
$29.5B
| $27.3M | 0.53% |
101,328
+22,853
| +29% | +$6.15M |
|